Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Oligonucleotide Synthesis Services Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The oligonucleotide synthesis services market has experienced substantial growth over recent years. Its valuation is predicted to climb from $2.93 billion in 2025 to $3.21 billion by 2026, advancing at a compound annual growth rate (CAGR) of 9.7%. This historical expansion can be primarily attributed to factors including the escalating use of PCR and sequencing, the broadening of molecular biology research, an increase in genomic testing, greater academic genomics funding, and intensified biotech R&D activities.

The oligonucleotide synthesis services market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach a size of $4.7 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.0%. The anticipated growth during this period is primarily driven by the increasing development of gene and cell therapy pipelines, the growing need for CRISPR and gene editing technologies, the broadening application of nucleic acid therapeutics, the expanded adoption of precision diagnostics, and the scaling up of clinical oligonucleotide production. Key trends anticipated for the forecast timeframe encompass high-throughput customized oligonucleotide manufacturing, services for modified and labeled oligonucleotides, GMP-grade oligonucleotide production, quickly delivered gene editing oligonucleotides, and sophisticated oligonucleotide purification processes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33245&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Jul_PR

Oligonucleotide Synthesis Services Market Growth Drivers: What Factors Are Accelerating Expansion?

A rising emphasis on personalized medicine is anticipated to drive the expansion of the oligonucleotide synthesis services market in the future. This medical approach involves tailoring treatment and prevention plans to an individual’s unique genetic, biological, and lifestyle attributes. Its adoption is growing thanks to developments in genomics and molecular diagnostics, which enable treatments to be specifically adjusted to a person’s genetic makeup for improved results. Oligonucleotide synthesis services support personalized medicine by facilitating the quick and accurate creation of bespoke DNA or RNA sequences. These are crucial for patient-specific diagnostics, targeted therapies, and gene-based treatments, thereby enabling interventions precisely matched to an individual’s genetic profile. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. The personalized treatments newly approved in 2023 also comprised seven cancer drugs and three for other diseases and conditions. Consequently, the heightened focus on personalized medicine is propelling the growth of the oligonucleotide synthesis services market.

Oligonucleotide Synthesis Services Market Segmentation And Category Breakdown

The oligonucleotide synthesis services market covered in this report is segmented –

1) By Type Of Oligonucleotide: Deoxyribonucleic Acid Oligonucleotides; Ribonucleic Acid Oligonucleotides; Peptide Nucleic Acids (PNAs); Locked Nucleic Acids (LNAs); Other Synthetic Nucleotides

2) By Synthesis Method: Solid Phase Synthesis; Liquid Phase Synthesis; Microarray Based Synthesis; Oligonucleotide Synthesis Via Automated Synthesizers; Enzymatic Synthesis

3) By Purity Level: Standard Purity; High Purity; Ultra High Purity; Custom Purity Solutions; Quality Control Measures

4) By Application: Diagnostics; Therapeutics; Research And Development; Gene Editing; Vaccine Development

5) By End User: Academic And Research Institutions; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Contract Research Organizations (CROs); Clinical Laboratories

Subsegments:

1) By Deoxyribonucleic Acid Oligonucleotides: Standard Deoxyribonucleic Acid Oligonucleotides; Modified Deoxyribonucleic Acid Oligonucleotides; Phosphorothioate Deoxyribonucleic Acid Oligonucleotides; Methylated Deoxyribonucleic Acid Oligonucleotides

2) By Ribonucleic Acid Oligonucleotides: Standard Ribonucleic Acid Oligonucleotides; Modified Ribonucleic Acid Oligonucleotides; Small Interfering Ribonucleic Acid Oligonucleotides; Micro Ribonucleic Acid Oligonucleotides

3) By Peptide Nucleic Acids: Standard Peptide Nucleic Acids; Modified Peptide Nucleic Acids; Functionalized Peptide Nucleic Acids

4) By Locked Nucleic Acids: Standard Locked Nucleic Acids; 2′-O-Methyl Locked Nucleic Acids; Gapmer Locked Nucleic Acids

5) By Other Synthetic Nucleotides: Morpholino Oligonucleotides; Phosphoramidite Oligonucleotides; Xeno Nucleic Acid Oligonucleotides; Synthetic Aptamers

Oligonucleotide Synthesis Services Market Trends: What Is Shaping Future Industry Growth?

Major companies engaged in the oligonucleotide synthesis services market are concentrating on developing their DNA and RNA production capacities to bolster therapeutic and diagnostic research efforts. These DNA and RNA production capabilities involve advanced techniques for generating and scaling high-quality genetic material, which are essential for enabling research, diagnostics, and the creation of biopharmaceutical therapies. As an illustration, in May 2025, Oligo Factory Inc., a US-based manufacturing enterprise, launched a low-scale oligo synthesis capability with the aim of broadening its support for therapeutic and diagnostic researchers and developers. This initiative facilitates the custom production of small batches of DNA/RNA, commencing at 50 nmol, for early-stage research and development across therapeutics, diagnostics, qPCR, NGS, and preclinical studies. It contributes to reducing costs and waste, ensures a swift turnaround (4 weeks or less) with GMP or ISO 13485 quality, and supports smooth scaling without necessitating vendor changes through portfolios such as FactorTx. This flexibility proves beneficial for researchers who require prototypes rather than extensive minimum orders.

Oligonucleotide Synthesis Services Market Competitive Analysis Of Major Industry Participants

Major companies operating in the oligonucleotide synthesis services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., QIAGEN N.V., Integrated DNA Technologies Inc., Sangon Biotech (Shanghai) Co. Ltd., Ajinomoto Co. Inc., Twist Bioscience Corporation, Sigma-Aldrich Co. LLC, Aldevron LLC, Bioneer Corporation, GenScript Biotech Corporation, BBI Life Sciences Ltd., Takara Bio Inc., BioServe Biotechnologies Ltd., Eurofins Genomics Germany GmbH, Bio-Synthesis Inc., TriLink BioTechnologies LLC, BioBasic Inc., Biosearch Technologies Inc., JenaBioscience GmbH, Geneworks Pty Ltd., HUWEL Life Science Co. Ltd., and SynoLigo Pvt. Ltd.

Access The Complete Oligonucleotide Synthesis Services Market Report:

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-services-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Jul_PR

Oligonucleotide Synthesis Services Market Largest Region By Revenue And Market Share

North America was the largest region in the oligonucleotide synthesis services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model